The commentary, Unintended Consequences of Glucagon-like Peptide-1 Receptor Agonists Medication in Children and Adolescents A Call to Action, was published as a perspective in the Journal of Clinical and Translational Science
Originally developed as a treatment for Type 2 diabetes, Semaglutide has been FDA-approved for weight loss in individuals with obesity
Many notice some loss a few weeks after starting injections, with more significant changes typically occurring after three to six months
As research continues, efforts are focused on understanding the long-term implications and safety of off-label dosing practices, with the goal of ensuring effective and safe treatment options for a wider range of patients
1,2 Off-Label Medications Off-label therapies, including amitriptyline, fluoxetine, gabapentin, cyclobenzaprine, and tramadol, have been shown to reduce patients fibromyalgia pain
"MGF and the role of muscle stem cells." Trends in Endocrinology & Metabolism